Sales for Abbott’s diabetes business jump 40% in Q2

Abbott (NYSE:ABT) shares were up today after the healthcare company posted second-quarter financial results that topped estimates on Wall Street.

For the three months ended June 30, Abbott posted profits of $733 million, or 41¢ per share, on sales of $7.77 billion. The company saw its quarterly profits grow 159% on sales growth of 17% compared with Q2 2017.

Get the full story at our sister site, Drug Delivery Business News.

The post Sales for Abbott’s diabetes business jump 40% in Q2 appeared first on MassDevice.

from MassDevice https://ift.tt/2NYoc48